durvalumab

Ligand id: 7985

Name: durvalumab

Immunopharmacology Comments
Durvalumab is an immuno-oncology drug targeting the immune check point protein PD-L1. Durvalumab boosts the immune system to fight cancer by blocking the inhibitory PD-1/PD-L1 pathway.